DSM reported higher volumes (+3%), which were the main sales driver (+3% to €1,945m) for continuing operations in Q3. EBITDA rose +22% to €246m and net profit attributable to shareholders skyrocketed from €33m to €318m fuelled by the €232m inflow from the gain on the IPO of Patheon. 9M operating CF jumped +69% to €644m due to lower other (€-78m after €-314m). By contrast, investing CF jumped to €-880m (€-37m) suffering from higher investments
03 Nov 2016
IPO gain pushes earnings
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
IPO gain pushes earnings
- Published:
03 Nov 2016 -
Author:
Martin Schnee -
Pages:
3
DSM reported higher volumes (+3%), which were the main sales driver (+3% to €1,945m) for continuing operations in Q3. EBITDA rose +22% to €246m and net profit attributable to shareholders skyrocketed from €33m to €318m fuelled by the €232m inflow from the gain on the IPO of Patheon. 9M operating CF jumped +69% to €644m due to lower other (€-78m after €-314m). By contrast, investing CF jumped to €-880m (€-37m) suffering from higher investments